{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:16Z","timestamp":1789628536181,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["GR-2009-1594586"],"award-info":[{"award-number":["GR-2009-1594586"]}]}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejim.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T15:55:12Z","timestamp":1428767712000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Erdheim-Chester disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Corrado","family":"Campochiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvise","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7428-315X","authenticated-orcid":false,"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejim.2015.03.004_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.md.0000145368.17934.91","article-title":"Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review","volume":"83","author":"Haroche","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2015.03.004_bb0015","doi-asserted-by":"crossref","unstructured":"Cavalli, G., et al., The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis. 72(10): p. 1691-5","DOI":"10.1136\/annrheumdis-2012-202542"},{"key":"10.1016\/j.ejim.2015.03.004_bb0020","doi-asserted-by":"crossref","unstructured":"Cavalli, G., et al., Diagnosing Erdheim-Chester disease. Ann Rheum Dis. 72(7): p. e19.","DOI":"10.1136\/annrheumdis-2013-203685"},{"key":"10.1016\/j.ejim.2015.03.004_bb0025","doi-asserted-by":"crossref","unstructured":"Jeon, I.S., S.S. Lee, and M.K. Lee, Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease. Pediatr Blood Cancer. 55(4): p. 745-7","DOI":"10.1002\/pbc.22636"},{"issue":"10","key":"10.1016\/j.ejim.2015.03.004_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/MPH.0b013e3181b76827","article-title":"Erdheim-Chester disease in childhood: a challenging diagnosis and treatment","volume":"31","author":"Tran","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.ejim.2015.03.004_bb0035","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.22280","article-title":"Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis","volume":"54","author":"Stoppacciaro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2015.03.004_bb0040","doi-asserted-by":"crossref","unstructured":"Dagna, L., et al., Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis. Rheumatology (Oxford). 49(6): p. 1203-6","DOI":"10.1093\/rheumatology\/kep461"},{"key":"10.1016\/j.ejim.2015.03.004_bb0045","doi-asserted-by":"crossref","unstructured":"Arnaud, L., et al., Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood. 117(10): p. 2783-90","DOI":"10.1182\/blood-2010-10-313510"},{"key":"10.1016\/j.ejim.2015.03.004_bb0050","doi-asserted-by":"crossref","unstructured":"Aouba, A., et al., Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood. 116(20): p. 4070-6","DOI":"10.1182\/blood-2010-04-279240"},{"key":"10.1016\/j.ejim.2015.03.004_bb0055","doi-asserted-by":"crossref","unstructured":"Dagna, L., et al., Tumor necrosis factor alpha as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab. J Clin Oncol. 30(28): p. e286-90","DOI":"10.1200\/JCO.2012.41.9911"},{"key":"10.1016\/j.ejim.2015.03.004_bb0060","doi-asserted-by":"crossref","unstructured":"Ferrero, E., et al., TNF-alpha in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab. Rheumatology (Oxford). 53(1): p. 198-200","DOI":"10.1093\/rheumatology\/ket246"},{"key":"10.1016\/j.ejim.2015.03.004_bb0065","doi-asserted-by":"crossref","unstructured":"Emile, J.F., et al., BRAF mutations in Erdheim-Chester disease. J Clin Oncol. 31(3): p. 398","DOI":"10.1200\/JCO.2012.46.9676"},{"key":"10.1016\/j.ejim.2015.03.004_bb0070","unstructured":"Cangi, M.G., et al., BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis."},{"issue":"12","key":"10.1016\/j.ejim.2015.03.004_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ejim.2015.03.004_bb0080","first-page":"671","article-title":"Targeting of the BRAF gene in papillary thyroid carcinoma (review)","volume":"22","author":"Li","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejim.2015.03.004_bb0085","doi-asserted-by":"crossref","unstructured":"Wellbrock, C. and A. Hurlstone, BRAF as therapeutic target in melanoma. Biochem Pharmacol. 80(5): p. 561-7","DOI":"10.1016\/j.bcp.2010.03.019"},{"key":"10.1016\/j.ejim.2015.03.004_bb0090","doi-asserted-by":"crossref","unstructured":"Tiacci, E., et al., BRAF mutations in hairy-cell leukemia. N Engl J Med. 364(24): p. 2305-15.","DOI":"10.1056\/NEJMoa1014209"},{"key":"10.1016\/j.ejim.2015.03.004_bb0095","doi-asserted-by":"crossref","unstructured":"Cavalli, G., et al., Oncogene-induced senescence as a new mechanism of disease: the paradigm of Erdheim-Chester disease. Front Immunol. 5: p. 281","DOI":"10.3389\/fimmu.2014.00281"},{"key":"10.1016\/j.ejim.2015.03.004_bb0100","doi-asserted-by":"crossref","unstructured":"Chapman, P.B., et al., Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 364(26): p. 2507-16","DOI":"10.1056\/NEJMoa1103782"},{"key":"10.1016\/j.ejim.2015.03.004_bb0105","doi-asserted-by":"crossref","unstructured":"Hauschild, A., et al., Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet. 380(9839): p. 358-65.","DOI":"10.1016\/S0140-6736(12)60868-X"},{"key":"10.1016\/j.ejim.2015.03.004_bb0110","doi-asserted-by":"crossref","unstructured":"Haroche, J., et al., Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 121(9): p. 1495-500","DOI":"10.1182\/blood-2012-07-446286"},{"key":"10.1016\/j.ejim.2015.03.004_bb0115","unstructured":"Haroche, J., et al., Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0120","doi-asserted-by":"crossref","unstructured":"Haroche, J., et al., Erdheim-Chester disease. Rheum Dis Clin North Am. 39(2): p. 299-311","DOI":"10.1016\/j.rdc.2013.02.011"},{"key":"10.1016\/j.ejim.2015.03.004_bb0125","doi-asserted-by":"crossref","unstructured":"Diamond, E.L., et al., Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 124(4): p. 483-92","DOI":"10.1182\/blood-2014-03-561381"},{"issue":"11 Pt 2","key":"10.1016\/j.ejim.2015.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.lpm.2007.04.032","article-title":"Erdheim-Chester disease","volume":"36","author":"Haroche","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.ejim.2015.03.004_bb0135","doi-asserted-by":"crossref","unstructured":"Wilejto, M. and O. Abla, Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol. 24(1): p. 90-6","DOI":"10.1097\/BOR.0b013e32834db53e"},{"issue":"3","key":"10.1016\/j.ejim.2015.03.004_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002560050351","article-title":"Erdheim-Chester disease: radiographic findings in five patients","volume":"27","author":"Bancroft","year":"1998","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.ejim.2015.03.004_bb0145","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1148\/radiol.2382041525","article-title":"Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement","volume":"238","author":"Dion","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2015.03.004_bb0150","doi-asserted-by":"crossref","unstructured":"Balink, H., et al., Scintigraphic diagnosis of Erdheim-Chester disease. J Clin Oncol. 29(16): p. e470-2","DOI":"10.1200\/JCO.2010.34.0307"},{"key":"10.1016\/j.ejim.2015.03.004_bb0155","doi-asserted-by":"crossref","unstructured":"Della Torre, E., et al., Erdheim-Chester disease: imaging-guided therapeutic approach. Clin Nucl Med. 36(8): p. 704-6.","DOI":"10.1097\/RLU.0b013e318217ade7"},{"key":"10.1016\/j.ejim.2015.03.004_bb0160","doi-asserted-by":"crossref","unstructured":"Arnaud, L., et al., CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 117(10): p. 2778-82","DOI":"10.1182\/blood-2010-06-294108"},{"issue":"1","key":"10.1016\/j.ejim.2015.03.004_bb0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00043426-199121000-00010","article-title":"A xanthogranulomatous histiocytosis in a child presenting with short stature","volume":"13","author":"Globerman","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.ejim.2015.03.004_bb0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jnnp.65.4.597","article-title":"Cerebral Erdheim-Chester disease: report of two cases with progressive cerebellar syndrome with dentate abnormalities on magnetic resonance imaging","volume":"65","author":"Pautas","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2007.03.014","article-title":"Unusual variants of non-Langerhans cell histiocytoses","volume":"57","author":"Caputo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0180","doi-asserted-by":"crossref","unstructured":"Pan, A., et al., Unusual manifestation of Erdheim-Chester disease. BMC Gastroenterol. 11: p. 77","DOI":"10.1186\/1471-230X-11-77"},{"issue":"5","key":"10.1016\/j.ejim.2015.03.004_bb0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.IOP.0000083642.15174.83","article-title":"Orbital xanthogranuloma: clinical and morphologic features in eight patients","volume":"19","author":"Karcioglu","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.ejim.2015.03.004_bb0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF03345108","article-title":"Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus","volume":"25","author":"Khamseh","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1998.00389.x","article-title":"Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis)","volume":"244","author":"Tritos","year":"1998","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0200","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1210\/jc.2006-2018","article-title":"Bilateral adrenal infiltration in Erdheim-Chester disease Report of seven cases and literature review.","volume":"92","author":"Haroche","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejim.2015.03.004_bb0205","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3880130","article-title":"Pulmonary pathology of Erdheim-Chester disease","volume":"13","author":"Rush","year":"2000","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejim.2015.03.004_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2559.1997.d01-614.x","article-title":"Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone","volume":"30","author":"Kambouchner","year":"1997","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ejim.2015.03.004_bb0215","first-page":"304","article-title":"Diffuse interstitial pneumonia revealing Erdheim-Chester's disease","volume":"11","author":"Madroszyk","year":"1994","journal-title":"Rev Mal Respir"},{"issue":"4","key":"10.1016\/j.ejim.2015.03.004_bb0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1440-1673.1984.tb02355.x","article-title":"Erdheim-Chester disease with bilateral exophthalmus and liver cell adenoma","volume":"28","author":"Palmer","year":"1984","journal-title":"Australas Radiol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0225","doi-asserted-by":"crossref","unstructured":"Arnaud, L., et al., Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum. 62(11): p. 3504-12.","DOI":"10.1002\/art.27672"},{"key":"10.1016\/j.ejim.2015.03.004_bb0230","article-title":"Cardiovascular manifestations of Erdheim-Chester disease","author":"Berti","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2015.03.004_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199901000-00002","article-title":"Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease","volume":"23","author":"Egan","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0240","doi-asserted-by":"crossref","unstructured":"Alharthi, M.S., et al., Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease. Eur J Echocardiogr. 11(7): p. E25.","DOI":"10.1093\/ejechocard\/jeq052"},{"issue":"25","key":"10.1016\/j.ejim.2015.03.004_bb0245","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1161\/CIRCULATIONAHA.108.825075","article-title":"Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients","volume":"119","author":"Haroche","year":"2009","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ejim.2015.03.004_bb0250","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1161\/CIRCULATIONAHA.108.767467","article-title":"Pericarditis heralding Erdheim-Chester disease","volume":"118","author":"Vaglio","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0255","first-page":"1550","article-title":"\u201cCoated aorta\u201d: a new sign of Erdheim-Chester disease","volume":"27","author":"Serratrice","year":"2000","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0260","first-page":"619","article-title":"Erdheim-Chester disease Case report with autopsy findings.","volume":"115","author":"Fink","year":"1991","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0265","doi-asserted-by":"crossref","first-page":"682","DOI":"10.5858\/2004-128-682-MIIED","article-title":"Myocardial involvement in Erdheim-Chester disease","volume":"128","author":"Loeffler","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejim.2015.03.004_bb0270","unstructured":"Lauretta, L., et al., [Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. Recenti Prog Med. 104(12): p. 637-42"},{"issue":"1","key":"10.1016\/j.ejim.2015.03.004_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10067-003-0801-7","article-title":"Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil","volume":"23","author":"Jendro","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0280","doi-asserted-by":"crossref","unstructured":"Broccoli, A., et al., Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. Rheumatol Int. 32(7): p. 2209-13","DOI":"10.1007\/s00296-011-1998-4"},{"issue":"9","key":"10.1016\/j.ejim.2015.03.004_bb0285","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-135-9-200111060-00027","article-title":"Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation","volume":"135","author":"Boissel","year":"2001","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ejim.2015.03.004_bb0290","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/thorax.58.11.1004","article-title":"Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone","volume":"58","author":"Bourke","year":"2003","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ejim.2015.03.004_bb0295","first-page":"163","article-title":"A case of Erdheim-Chester disease with bilateral orbital involvement","volume":"17","author":"Wu","year":"2001","journal-title":"Yan Ke Xue Bao"},{"issue":"8","key":"10.1016\/j.ejim.2015.03.004_bb0300","first-page":"1121","article-title":"High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement","volume":"91","author":"Gaspar","year":"2006","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.ejim.2015.03.004_bb0305","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood-2005-06-2238","article-title":"Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha","volume":"106","author":"Braiteh","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb0310","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9394(01)01141-2","article-title":"Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease","volume":"132","author":"Esmaeli","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2015.03.004_bb0315","doi-asserted-by":"crossref","unstructured":"Suzuki, H.I., et al., Erdheim-Chester disease: multisystem involvement and management with interferon-alpha. Leuk Res. 34(1): p. e21-4","DOI":"10.1016\/j.leukres.2009.07.026"},{"issue":"10","key":"10.1016\/j.ejim.2015.03.004_bb0320","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/art.22165","article-title":"Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients","volume":"54","author":"Haroche","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2015.03.004_bb0325","doi-asserted-by":"crossref","unstructured":"Aubert, O., et al., Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra. Joint Bone Spine. 80(2): p. 206-7.","DOI":"10.1016\/j.jbspin.2012.07.005"},{"key":"10.1016\/j.ejim.2015.03.004_bb0330","doi-asserted-by":"crossref","unstructured":"Tran, T.A., et al., Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum. 63(12): p. 4031-2.","DOI":"10.1002\/art.30638"},{"key":"10.1016\/j.ejim.2015.03.004_bb0335","doi-asserted-by":"crossref","unstructured":"Killu, A.M., J.J. Liang, and A.S. Jaffe, Erdheim-Chester disease with cardiac involvement successfully treated with anakinra. Int J Cardiol. 167(5): p. e115-7.","DOI":"10.1016\/j.ijcard.2013.04.057"},{"key":"10.1016\/j.ejim.2015.03.004_bb0340","doi-asserted-by":"crossref","unstructured":"Dietrich, S., et al., Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. J Clin Oncol. 31(19): p. e300-3.","DOI":"10.1200\/JCO.2012.45.9495"},{"key":"10.1016\/j.ejim.2015.03.004_bb0345","doi-asserted-by":"crossref","unstructured":"Dietrich, S., et al., BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med. 366(21): p. 2038-40.","DOI":"10.1056\/NEJMc1202124"},{"issue":"10","key":"10.1016\/j.ejim.2015.03.004_bb0350","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1002\/art.24848","article-title":"18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease","volume":"60","author":"Arnaud","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2015.03.004_bb9000","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2013-02-482984","article-title":"Detection of an NRAS mutation in Erdheim-Chester disease","volume":"122","author":"Diamond","year":"2013","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.ejim.2015.03.004_bb9005","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T22:55:39Z","timestamp":1651704939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0953620515000771"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.03.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erdheim-Chester disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}